FDLI Publishes Case Studies on Top Food & Drug Law Cases of 2025

July 10, 2026

IFLR's Neal Fortin participated in FDLI's "Top Food & Drug Cases, 2025" publication with his entry on California Chamber of Commerce. v. Bonta.

The Food & Drug Law Institute (FDLI) has published it's annual list of top food and drug cases.

Neal Fortin, Director of MSU's IFLR, contributed with a chapter on California Chamber of Commerce v. Bonta. This is a case in which the U.S. District Court for the Eastern District of California ruled that California’s warning requirements for dietary acrylamide violate the First Amendment. The court issued a permanent injunction prohibiting enforcement of Proposition 65 (Prop 65) warnings for acrylamide in food.

Link here for the full report.

FDLI's Top Food and Drug Cases 2025

Federal Communications Commission v. Consumers’ Research
Natural Grocers v. Rollins
Zyla Life Sciences LLC v. Wells Pharma of Houston LLC
In re Folgers Marketing Litigation
Novartis Pharmaceuticals Corporation v. Kennedy
Wulferic, LLC v. FDA
California Chamber of Commerce. v. Bonta
Eli Lilly & Co. v. Kennedy
American Clinical Laboratory Association v. FDA
Silverstein v. CoolSculpting – Zeltiq Aesthetics, Inc.
The Rise of Big Food Litigation
2025 Significant Settlements

Learn about the laws behind these cases with our online graduate courses:

Disclaimer.

The Institute for Food Laws and Regulations (IFLR) at Michigan State University offers graduate degree and continuing education programs designed specifically for food industry professionals. All courses are delivered 100% online and asynchronously, allowing students to manage their studies alongside work and personal responsibilities. Students have the option to pursue a certificate in U.S. or international food law, or work toward a Master of Science in Food Regulatory Affairs. Some students begin by enrolling in a single course to address a specific challenge in their workplace and choose to continue their studies from there.